VALIRX PLC

Director's Dealing • Aug 7, 2020

National Storage Mechanism | Additional information

RNS Number : 5433V

ValiRx PLC

07 August 2020

VALIRX PLC

("ValiRx", the "Company" or the "Group")

Director Dealing

London, UK 7 August 2020: ValiRx Plc (AIM: VAL), the clinical stage biotechnology company announces the following dealing in the ordinary shares of the Company made by a Director.

On 7 August 2020, the Company was informed that Dr Kevin Cox, Non-executive Chairman of the Company, acquired 117,000 ValiRx ordinary shares at an average price of 8.2 pence per share on 7 August 2020, representing approximately 0.22% of the Company's issued ordinary share capital. Following this acquisition, Dr Cox now holds an interest in 250,333 ValiRx ordinary shares, representing approximately 0.46% of the Company's issued ordinary share capital.

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

For further information please contact:

ValiRx plc	Tel: +44 (0) 20 7073 2628 www.valirx.com
Suzanne Dilly	Suzanne.Dilly@valirx.com
Cairn Financial Advisers LLP(Nominated Adviser) Liam Murray / Jo Turner / Ludovico Lazzaretti	Tel: +44 (0) 20 7213 0880
Peterhouse Capital Limited (Sole Broker) Duncan Vasey / Lucy Williams / Eran Zucker	Tel: +44 (0) 20 7469 0930

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014

1

Details of the person discharging managerial responsibilities/person closely associated

a.

Name

Dr Kevin Cox

2

Reason for notification

a.

Position/Status

Non-executive Chairman

b.

Initial notification/

Amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

ValiRx PLC

b.

LEI

	213800VQKB9SJCQDET40

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the financial instrument, type of instrument

Identification Code

Ordinary Shares

ISIN: GB00BLH13C52

b.

Nature of the transaction

On market Purchase

c.

Price(s) and volume(s)

Price(s)

Volume(s)

8.2 pence

117,000

d.

Aggregated information

- Aggregated Volume

- Price

N/A

e.

Date of the transaction

07/08/2020

f.

Place of the transaction

London, UK

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHBXGDIIBGDGGR